Cardiac morbidity burden before and after ECD diagnosis
| . | Before ECD diagnosis . | After ECD diagnosis . | ||||
|---|---|---|---|---|---|---|
| ECD-noC (n = 65) . | ECD-C (n = 39) . | P value . | ECD-noC (n = 65) . | ECD-C (n = 39) . | P value . | |
| Any CV morbidity present,∗ n (%) | 27 (42) | 28 (72) | .004 | 36 (55) | 33 (85) | .003 |
| Total number of comorbidities, median (IQR) and n (%) | 0 (0-1) | 1 (0-2) | <.001 | 1 (0-1) | 2 (1-4) | <.001 |
| 0 | 38 (59) | 11 (28) | 29 (45) | 6 (15) | ||
| 1 | 20 (31) | 15 (39) | 21 (32) | 10 (26) | ||
| 2 | 4 (6) | 5 (13) | 7 (11) | 7 (18) | ||
| 3 | 1 (2) | 4 (10) | 4 (6) | 6 (15) | ||
| 4 | 2 (3) | 2 (5) | 1 (2) | 4 (10) | ||
| 5 | 0 (0) | 2 (5) | 2 (3) | 5 (13) | ||
| 6 | 0 (0) | 0 (0) | 1 (2) | 1 (3) | ||
| CV count ≥2, n (%) | 7 (11) | 13 (33) | .009 | 15 (23) | 23 (59) | <.001 |
| CV count ≥3, n (%) | 3 (5) | 8 (21) | .018 | 8 (12) | 16 (41) | .001 |
| CV count ≥4, n (%) | 2 (3) | 4 (10) | .19 | 4 (6) | 10 (26) | .007 |
| Highest severity grade, median (IQR) and n (%) | 0 (0-2) | 2 (0-4) | <.001 | 2 (0-2) | 3 (2-4) | <.001 |
| 0 | 38 (58) | 11 (28) | 29 (45) | 6 (15) | ||
| 1 | 0 (0) | 3 (8) | 1 (2) | 3 (8) | ||
| 2 | 20 (31) | 10 (26) | 24 (37) | 8 (21) | ||
| 3 | 5 (8) | 1 (3) | 6 (9) | 4 (10) | ||
| 4 | 2 (3) | 14 (36) | 5 (8) | 18 (46) | ||
| Highest severity grade, n (%) | <.001 | <.001 | ||||
| 1-3 | 63 (97) | 25 (64) | 60 (92) | 21 (54) | ||
| ≥4 | 2 (3) | 14 (36) | 5 (8) | 18 (46) | ||
| . | Before ECD diagnosis . | After ECD diagnosis . | ||||
|---|---|---|---|---|---|---|
| ECD-noC (n = 65) . | ECD-C (n = 39) . | P value . | ECD-noC (n = 65) . | ECD-C (n = 39) . | P value . | |
| Any CV morbidity present,∗ n (%) | 27 (42) | 28 (72) | .004 | 36 (55) | 33 (85) | .003 |
| Total number of comorbidities, median (IQR) and n (%) | 0 (0-1) | 1 (0-2) | <.001 | 1 (0-1) | 2 (1-4) | <.001 |
| 0 | 38 (59) | 11 (28) | 29 (45) | 6 (15) | ||
| 1 | 20 (31) | 15 (39) | 21 (32) | 10 (26) | ||
| 2 | 4 (6) | 5 (13) | 7 (11) | 7 (18) | ||
| 3 | 1 (2) | 4 (10) | 4 (6) | 6 (15) | ||
| 4 | 2 (3) | 2 (5) | 1 (2) | 4 (10) | ||
| 5 | 0 (0) | 2 (5) | 2 (3) | 5 (13) | ||
| 6 | 0 (0) | 0 (0) | 1 (2) | 1 (3) | ||
| CV count ≥2, n (%) | 7 (11) | 13 (33) | .009 | 15 (23) | 23 (59) | <.001 |
| CV count ≥3, n (%) | 3 (5) | 8 (21) | .018 | 8 (12) | 16 (41) | .001 |
| CV count ≥4, n (%) | 2 (3) | 4 (10) | .19 | 4 (6) | 10 (26) | .007 |
| Highest severity grade, median (IQR) and n (%) | 0 (0-2) | 2 (0-4) | <.001 | 2 (0-2) | 3 (2-4) | <.001 |
| 0 | 38 (58) | 11 (28) | 29 (45) | 6 (15) | ||
| 1 | 0 (0) | 3 (8) | 1 (2) | 3 (8) | ||
| 2 | 20 (31) | 10 (26) | 24 (37) | 8 (21) | ||
| 3 | 5 (8) | 1 (3) | 6 (9) | 4 (10) | ||
| 4 | 2 (3) | 14 (36) | 5 (8) | 18 (46) | ||
| Highest severity grade, n (%) | <.001 | <.001 | ||||
| 1-3 | 63 (97) | 25 (64) | 60 (92) | 21 (54) | ||
| ≥4 | 2 (3) | 14 (36) | 5 (8) | 18 (46) | ||
Bold indicates statistical significance (2-sided P < .05).
The CV risk factors and cardiac conditions included for this analysis were the following: HTN, CAD, MI, CHF, atrial fibrillation, pericardial effusion, valvular disease, and conduction disorders.